Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Oliver Funk

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|November 14, 2002
Linking DNA damage to cell cycle checkpointsTemesgen Samuel, H Oliver Weber, Jens Oliver Funk
Journal of Virology|September 20, 2002
Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cellsAnna-Marija Helt, Jens Oliver Funk, Denise A Galloway
Oncogene|June 26, 2002
Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathwaysH Oliver Weber, Temesgen Samuel, Pia Rauch, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Multiple disseminated large-cell acanthomas of the skin associated with human papillomavirus type 6Thomas Berger, Eggert Stockfleth, Thomas Meyer, et al.
European Journal of Immunology|October 28, 2003
The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergyBerlinda Verdoodt, Tino Blazek, Pia Rauch, et al.
Oncology Reports|November 8, 2005
Artesunate in the treatment of metastatic uveal melanoma--first experiencesThomas G Berger, Detlef Dieckmann, Thomas Efferth, et al.
The Journal of Investigative Dermatology|November 14, 2017
ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of PsoriasisJessica M Fuhriman, Mårten C G Winge, Helena Haberstock-Debic, et al.
Biochimica Et Biophysica Acta|November 11, 2006
Neuronal cell cycle re-entry mediates Alzheimer disease-type changesAndrew McShea, Hyoung-gon Lee, Robert B Petersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2015
A Small Molecule Inhibitor of ITK and RLK Impairs Th1 Differentiation and Prevents Colitis Disease ProgressionHyoung-Soo Cho, Hyun Mu Shin, Helena Haberstock-Debic, et al.
Molecular Pharmacology|July 19, 2003
Molecular modes of action of artesunate in tumor cell linesThomas Efferth, Axel Sauerbrey, Armin Olbrich, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|November 14, 2002
Linking DNA damage to cell cycle checkpointsTemesgen Samuel, H Oliver Weber, Jens Oliver Funk
Journal of Virology|September 20, 2002
Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cellsAnna-Marija Helt, Jens Oliver Funk, Denise A Galloway
Oncogene|June 26, 2002
Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathwaysH Oliver Weber, Temesgen Samuel, Pia Rauch, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Multiple disseminated large-cell acanthomas of the skin associated with human papillomavirus type 6Thomas Berger, Eggert Stockfleth, Thomas Meyer, et al.
European Journal of Immunology|October 28, 2003
The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergyBerlinda Verdoodt, Tino Blazek, Pia Rauch, et al.
Oncology Reports|November 8, 2005
Artesunate in the treatment of metastatic uveal melanoma--first experiencesThomas G Berger, Detlef Dieckmann, Thomas Efferth, et al.
The Journal of Investigative Dermatology|November 14, 2017
ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of PsoriasisJessica M Fuhriman, Mårten C G Winge, Helena Haberstock-Debic, et al.
Biochimica Et Biophysica Acta|November 11, 2006
Neuronal cell cycle re-entry mediates Alzheimer disease-type changesAndrew McShea, Hyoung-gon Lee, Robert B Petersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2015
A Small Molecule Inhibitor of ITK and RLK Impairs Th1 Differentiation and Prevents Colitis Disease ProgressionHyoung-Soo Cho, Hyun Mu Shin, Helena Haberstock-Debic, et al.
Molecular Pharmacology|July 19, 2003
Molecular modes of action of artesunate in tumor cell linesThomas Efferth, Axel Sauerbrey, Armin Olbrich, et al.
Pageof 2